Clinical Chemist-Pharmacologist

Comprehensive knowledge of various laboratory techniques including clinical chemistry and molecular diagnostics technique including, several clinical chemistry analyzers, mutation analysis, cloning process and polymerase chain reaction, gel electrophoresis of DNA, RNA, and protein; routine Bioinformatic knowledge in molecular techniques, LC-MS/MS and knowledge of Next Generation Sequencing process and having several articles in molecular biology area.

Highly analytical and results-oriented professional, comprehensive research experience exemplified by publications in high-impact factor journals

Demonstrated in-depth clinical and management knowledge, interpersonal and communication skills to manage and nurture institutional affiliations and to interact with external physicians and executives

Ability to organize work effectively to achieve timely progress on multiple tasks simultaneously, to establish priorities and distribute effort appropriately among tasks, meet deadlines, and maintain a high level of productivity

Knowledge and hands on training in different areas of clinical laboratory including general chemistry, special chemistry, toxicology and hematology, Molecular techniques as well as different types of automated and semi-automated analyzers including reflectometers, nephelometers, ion specific electrodes, blood gas apparatus, co-oximeters, mass spectrometry and different chemistry analyzers, Q-PCR, DNA extraction, process automation and robotic.

Experience and knowledge of the operation of clinical laboratory equipment in terms of precision, accuracy, methods development for requested tests as per CLSI guidelines and CLIA and CAP requirements, laboratory quality management, establishing satisfactory quality control, and quality assessments. Familiar with regulatory documents IND/IMPD/NDA. Excellent knowledge in FDA and EMA regulations and cGMP, ICH guidelines (Q8, Q9, Q12)

Knowledge of writing standard operating procedures (SOPs), data capture and quality review, analytical methods, assay validation, and documents for regulatory requirement and manuscripts.

Teaching and supervisory experience. Effective in team leadership, organizational management, business analysis and project management; along with the ability to work and generate independent decisions within fast-paced environment.

Skills

Comprehensive knowledge of various laboratory techniques

In-depth familiarity with good clinical practices (GCP/ICH) principles

Holding accountability for the experimental design, scientific and medical data process, as well as integration of policies and procedures while employing project management and multitasking ability.

In-depth knowledge of medical information and project management and drug safety.

Working with numerous laboratory instruments such as ADVIA Centaur XP, high performance liquid chromatography (HPLC), gas chromatograph/mass spectrometer (GC-MS)

Efficiently utilizing expertise with molecular biology techniques, innovative research, immunochemical assay, and reverse transcription polymerase chain reaction.

Industry-based expertise with titer assay validation, recombinant deoxyribonucleic acid technology including the cloning process and polymerase chain reaction through gel electrophoresis of DNA, ribonucleic acid RNA, and protein.

Clinical laboratory management; method development and laboratory quality management as per ISO and CAP; CLIA and CLSI (NCCLS) guidelines

Creative Team Leadership

Awards

Award on Poster Presentation, Banff, 2003

MSACL Young Investigator Travel Grant, palm Springs, California, 2017

Travel Grants and Honorable Abstract Winner in the Area of Patient Safety, AACC Annual Scientific Meeting in San Diego, California, 2017

Professional Experience

CALIFORNIA DEPARTMENT OF PUBLIC HEALTH, RICHMOND, CA Research Scientist III Comprehensive experience of various laboratory techniques and instruments including GC-MS and LC-MS, supervising the junior scientists, laboratory quality management, establishing satisfactory quality control, and quality assessments 02/2018 to Present

Selected Accomplishments:

Method development and laboratory quality management

Comprehensive experience of various laboratory techniques and instruments

Certificate: advanced training of GC-MS and LC-MS

Certificate: leadership and management

SAN FRANCISCO GENERAL HOSPITAL, SAN FRANCISCO, CA The ComACC accredited clinical chemistry-training program aimed to train PhD individuals for clinical laboratory management; method development and laboratory quality management as per ISO and CAP; CLIA and CLSI (NCCLS) guidelines in area of chemistry, microbiology, hematology and molecular diagnostics laboratories to be able to be director or manager of a lab

Supervisory experience in the acute care facility, San Francisco General Hospital

Attending clinical pharmacology & toxicology seminars since January 2016

Teaching the CLS students 05/2016-02/2018

Selected Accomplishments:

clinical laboratory management; method development and laboratory quality management as per ISO and CAP; CLIA and CLSI (NCCLS) guidelines

Comprehensive experience of various laboratory techniques and instruments

Working with laboratory information system (LIS)

Clinical trial and biomarker assay experience

Regulatory affairs: The IND, NDA and Post marketing

Leadership certificate, UCSF

DRUGSTORE PHARMACY, AND STADACONA HOSPITAL (CANADIAN FORCES BASE CLINIC) HALIFAX, NS, CANADA Pharmacist/Pharmacy Manager (supervisory experience in the acute care facility)

06/2009–05/2015

Selected Accomplishments:

Took full responsibility in overseeing pharmaceutical operations including prescription dispensing and compounding, product Safety, and quality assurance. Advanced knowledge and broad expertise of policies, practices, and systems.

Remarkable ability to work and make independent decisions, understood complex medical information, and took the initiative to lead projects and assignments. Comfortable multi-tasking in a faced paced environment

Rendered consultative services to staff physicians on the optimal use of medicines as well as drug information and drug safety and toxic effects.

Facilitated training of pharmacy technicians, while carrying out key tasks such as project and staff management, inventory, business analysis and data coding and verification in adherence to specified research protocols.

THE HOSPITAL FOR SICK CHILDREN, TORONTO, ON Postdoctoral Fellow 02/2005–10/2008

UNIVERSITY OF LAUSANNE, DEPARTMENT OF PHARMACOLOGY AND TOXICOLOGY, LAUSANNE, SWITZERLAND Postdoctoral Fellow 08/2004–02/2005

UNIVERSITY OF BERN, INSELSPITAL, BERN, SWITZERLAND Ph.D. researcher 06/2001–07/2004

Selected Accomplishments (06/2001-02/2015):

Expertise in titer assay validation, mutation analysis, ribonucleic acid RNA, protein, recombinant DNA technology including the cloning process and polymerase chain reaction through gel electrophoresis of DNA, conditional knockout mice using Cre-Lox and FLP-FRT recombination system, Northern blotting and Southern blotting techniques

Knowledge in many areas of molecular biology, clinical genetics, clinical biochemistry, biostatistics and instrumentation.

Practiced many laboratory techniques such as mutational analysis by PCR/SSCP, site-directed mutagenesis, gene targeting technology, Q-PCR, hybridization analysis, pathology studies, immunohistochemistry, immunofluorescence (confocal), luciferase assay, gel electrophoresis, and many others.

Held accountability for the experimental design, scientific and medical data process, as well as integration of policies and procedures while employing project management and multitasking ability.

Maintained active involvement in determining alternative solutions and providing corrective action through in-depth knowledge of medical information and project management and drug safety and toxicology.

Displayed competency in establishing and verifying current good manufacturing practices testing on all biological products, encoded data in alignment with research protocol and coding procedures to database for analysis.

Efficiently utilized expertise with molecular biology techniques, innovative research, immunochemical assay, and reverse transcription polymerase chain reaction.

Employed comprehensive knowledge of various laboratory techniques.

Displayed in-depth familiarity with good clinical practices (GCP/ICH) principles.

Comprehensive experience of various laboratory techniques

Efficiently utilized expertise with molecular biology techniques, working with human and animal tissues, fluorescence activated cell sorter (FACS) and ELISA, innovative research, immunochemical assay, and reverse transcription polymerase chain reaction,

Provided leadership and support to the Internal Department through SOPs.

Demonstrated skills and knowledge of biomarker assay.

DR. SHARIATI HOSPITAL, BANDAR ABBASS, IRAN Clinical Pharmacist (Manager with supervisory experience in the acute care facility, Shariati Hospital) 04/1999–06/2001

PHARMACEUTICAL AND NUTRITION MANAGEMENT GROUP, RASHT, IRAN Group Leader

08/1997–04/1999

Selected Accomplishments:

Executed first-rate customer, patient counseling, and medication management services as well as time and project management for the department.

Clinical Trial experience, evaluating the efficacy of Fluvastatin & Lovastatin in comparison with placebo in hypercholesterolemic patients

Teaching

TEACHER/MENTOR Provided instructional services to nurses and pharmacy technicians; undergraduate and graduate students 03/98-present

Education and Certificates

CLINICAL CHEMISTRY SCIENTIST CERTIFICATE: University of San Francisco, CA 2018

License No: MTC-02003959

COMACC ACCREDITED POSTDOCTORAL TRAINING PROGRAM IN CLINICAL CHEMISTRY: University of California San Francisco, San Francisco General Hospital, SF, CA, US 2018

CANADIAN PHARMACY SKILL CERTIFICATE PROGRAM: University of Toronto, ON, Canada 2010

DOCTOR OF PHILOSOPHY IN PHARMACOLOGY: University of Bern, Bern, Switzerland 2004

DOCTOR OF PHARMACY: University of Tehran, Tehran, Iran 1997

Professional Development

SCIENTIFIC LEADERSHIP AND MANAGEMENT SKILLS COURSE: San Francisco, CA 11/2017

HANDS-ON DEVELOPMENT AND VALIDATION OF LC-MS/MS ASSAYS FOR CLINICAL RESEARCH: Redwood City, CA 11/2016

NORTH AMERICA ADVANCED QTRAP TRAINING FOR QUANTITATIVE AND QUALITATIVE WORKFLOWS: Redwood City, CA 08/2016

CLINICAL PHARMACOLOGY TRAINING COURSES AND LECTURE: UCSF, SF, CA 06/2016-02/2018

REGULATORY AFFAIRS CERTIFICATE PROGRAM: UCSC, Santa Clara, CA 2015

CRA TRAINING ONLINE COURSE: Clinical Research Associate Training Institute (Online)

PROJECT MANAGEMENT: Humber College, Toronto, ON, Canada 2008

GOOD MANUFACTURING PRACTICE (GMP), QUALITY CONTROL, AND QUALITY ASSURANCE

Pharmaceutical Sciences Group (PSG), Toronto, ON, Canada 2008

Presentation and Publication

4 Poster Presentations

9 publications in high-impact factor journals

100s of presentations

List of Publications

Goodnough R., Li K, Fouladkou F., Lynch K.L., Shah M., Smollin C.G., Blanc P.D. (2018). Notes from the Field: Toxic Leukoencephalopathy Associated with Tianeptine Misuse - California, 2017.

MMWR Morb Mortal Wkly Rep, 67(27):769-770

Fouladkou F., Lu C., Jiang C., She Y., Walls J.R, Bruneau B.G. and Rotin D.(2010). The ubiquitin ligase Nedd4-1 is required for heart development and is a suppressor of Thrombospondin-1. J Biol Chem, 285(9), 6770-80.

Fouladkou, F., Landry, T., Kawabe, H., Neeb, A., Lu, C., Brose, N., Stambolic, V., and Rotin, D. (2008). The Ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci, 105(25), 8585-90.

Fakitsas,P., Adam, G., Daidié, D., van Bemmelen, M.X., Fouladkou, F., Patrignani, A., Wagner, U., Warth, R., Camargo, S.M., Staub, O. and Verrey,F. (2007). Early aldosterone-induced gene product regulates the epithelial sodium channel by deubiquitylation. J Am Soc Nephrol, 18(4), 1084-92.

Bruce, C., Debonneville, A., Fouladkou, F., Kanelis, V., Rotin, D., and Staub, O. (2008). Regulation of Nedd4-2 self-ubiquitylation and stability by a PY motif located within its HECT-domain. Biochem J., 415(1), 155-63.

Alikhani-Koopaei, Fouladkou, F., Fustier, P., R., Cenni, B., Sharma, A.R., Frey B.M., Frey F.J. (2007). Identification, functional characterization, and relevance for salt sensitivity of polymorphisms in the promoter of the human 11-Beta-hydroxysteroid dehydrogenase type 2 gene. FASEB, 21(13), 3618-3628.

Alikhani-Koopaei, R., Fouladkou, F., Frey, B.M., and Frey, F.J. (2004). Epigenetic regulation of 11 Beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Invest, 114(8), 1146-57.

Fouladkou, F., Alikhani-Koopai, R., Vogt, B., Flores, S.Y., Malbert-Colas, L., Lecomte, M.C., Loffing, J., Frey, F.J., Frey, B.M., and Staub, O. (2004). A naturally occurring human Nedd4-2 mutant shows impaired ENaC regulation due to defective phosphorylation by Sgk1. Am.J.Physiol., 287(3), F550-61.

Moradmand, S., Niakan, M.R., Fouladkou, F., and Shafiee, A. (1998). Clinical Trial to evaluate the efficacy of Fluvastatin & Lovastatin in comparison with placebo in hypercholesterolemic patients. Med J Islamic Rep Iran, 12(3), 229-233.

List of Poster Presentations

Li K., Vo K., Repplinger D., Fouladkou F., Lynch K., Smollin C. (2017). Two cases of ventricular dysrhythmias from aconitine poisoning. Poster ID :656, NACCT 2017.

Fouladkou F., Wu A.H.B., and Lynch K.L. (2017). Dietary Biotin Causes a Negative Interference for Troponin in the Advia Centaur Assay. Poster ID : A-076, AACC 2017.

Fouladkou, F., Vogt. B., et al.. “Identification and characterization of a human Nedd4-2 variant defective for regulation by Sgk1.” APS Conference on "Aldosterone & ENaC: from Genetics to Physiology.” Banff, Canada. September 2003.

Fouladkou F., Lynch K.L., and Wu A.H.B. (2018). Quantitation of Bilirubin from Dry Blood Spots for Biliary Atresia and Kernicterus Using LC-MS. Poster ID : 36C, MSACL 2018.

Contact this candidate